GB201215414D0 - Composition and use - Google Patents

Composition and use

Info

Publication number
GB201215414D0
GB201215414D0 GBGB1215414.2A GB201215414A GB201215414D0 GB 201215414 D0 GB201215414 D0 GB 201215414D0 GB 201215414 A GB201215414 A GB 201215414A GB 201215414 D0 GB201215414 D0 GB 201215414D0
Authority
GB
United Kingdom
Prior art keywords
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1215414.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oxford University Innovation Ltd
Original Assignee
Oxford University Innovation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxford University Innovation Ltd filed Critical Oxford University Innovation Ltd
Priority to GBGB1215414.2A priority Critical patent/GB201215414D0/en
Publication of GB201215414D0 publication Critical patent/GB201215414D0/en
Priority to PCT/GB2013/052276 priority patent/WO2014033463A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/26—Infectious diseases, e.g. generalised sepsis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Urology & Nephrology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Analytical Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GBGB1215414.2A 2012-08-30 2012-08-30 Composition and use Ceased GB201215414D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1215414.2A GB201215414D0 (en) 2012-08-30 2012-08-30 Composition and use
PCT/GB2013/052276 WO2014033463A1 (en) 2012-08-30 2013-08-29 Prevention of the interaction between tenascin-c and mir-155 to treat sepsis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1215414.2A GB201215414D0 (en) 2012-08-30 2012-08-30 Composition and use

Publications (1)

Publication Number Publication Date
GB201215414D0 true GB201215414D0 (en) 2012-10-17

Family

ID=47074954

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1215414.2A Ceased GB201215414D0 (en) 2012-08-30 2012-08-30 Composition and use

Country Status (2)

Country Link
GB (1) GB201215414D0 (en)
WO (1) WO2014033463A1 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8697672B2 (en) * 2007-05-16 2014-04-15 California Institute Of Technology Microrna inhibition for the treatment of inflammation and myeloproliferative disorders
WO2010090272A1 (en) * 2009-02-06 2010-08-12 学校法人東京理科大学 Remedy for chronic inflammation and antibody to be used therein
CA2767409C (en) * 2009-07-24 2018-10-30 The Regents Of The University Of California Methods and compositions for treating and preventing disease associated with .alpha.v.beta.5 integrin

Also Published As

Publication number Publication date
WO2014033463A1 (en) 2014-03-06

Similar Documents

Publication Publication Date Title
HK1203493A1 (en) Substituted azabicycles and use thereof
HK1202545A1 (en) New diazaspirocycloalkane and azaspirocycloalkane
HK1199023A1 (en) Substituted benzothienylpyrrolotriazines and uses thereof
HK1200822A1 (en) Substituted dipyridylamines and uses thereof
EP2927281A4 (en) Resin composition and use thereof
ZA201408594B (en) Xylitol-based anti-mucosal compositions and related methods and compositions
HK1210949A1 (en) Combinations and uses thereof
HK1203198A1 (en) Substituted phenylimidazopyrazoles and use thereof
EP2895569A4 (en) Adhesive compositions and use thereof
GB201315350D0 (en) Methods and compositions
IL238532A0 (en) Synbiotic composition and use thereof
HK1201270A1 (en) Tetrazol-5-yl- and triazol-5-yl-aryl compounds and use thereof as herbicides -5---5--
EP2874641A4 (en) Glutathione-elevating compositions and uses thereof
GB201315347D0 (en) Methods and compositions
HK1210809A1 (en) Beta-hexosyl-transferases and uses thereof
IL238531A0 (en) Synbiotic composition and use thereof
HK1207154A1 (en) C1q-adiponectin complex and use thereof c1q-
HUE032878T2 (en) Dermo-protective and dermo-balancing composition
GB201210989D0 (en) Composition and device
GB201215414D0 (en) Composition and use
GB201219884D0 (en) New composition and preparation thereof
GB201213726D0 (en) Novel compounds and their use
GB201222541D0 (en) Kiddibidet and pottibidet
IL218974A0 (en) Conaction bitwen coutch and playels
GB201202021D0 (en) Co-sleeper and breastfeeder

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)